[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100571816":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":21,"centralContacts":27,"locations":32,"responsibleParty":51,"collaborators":54,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":10,"eligibilityCriteria":64,"healthyVolunteers":65,"sex":66,"minAge":10,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":78,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of Washington","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"Patients with presumed germline retinoblastoma due to RB1 mutation",null,[12],"Genetic: Targeted Long-read sequencing",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"GENETIC","Targeted Long-read sequencing","All patient's will undergo targeted long-read sequencing to resolve genomic and epigenomic signatures of the RB1 gene",[9],[20],"Long-read sequencing",[22,25],{"name":23,"affiliation":5,"role":24},"Debarshi Mustafi, MD PhD","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":5,"role":24},"Andrew W Stacey, MD",[28],{"name":23,"role":29,"phone":30,"phoneExt":10,"email":31},"CONTACT","206-683-6305","debarshi@uw.edu",[33],{"facility":5,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"RECRUITING","Seattle","Washington","98109","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-122.33207,47.60621,{"lat":44,"lon":43},[47,49,50],{"name":23,"role":29,"phone":48,"phoneExt":10,"email":10},"206-221-2029",{"name":23,"role":24,"phone":10,"phoneExt":10,"email":10},{"name":26,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":24,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Debarshi Mustafi","Assistant Professor: School of Medicine, Ophthalmology",[55],{"name":56,"class":57},"National Eye Institute (NEI)","NIH","100571816","detailed-phenotypic-and-genotype-study-to-correlate-rb1-mutations-relating-to-primary-ocular-tumors-and-secondary-extra-ocular-metastasis-100571816",false,"NCT06725173","Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.","Genetic Associations of Ocular Cancers","Inclusion Criteria:\n\n* Patients with molecularly proven retinoblastoma due to RB1 or a typical clinical retinoblastoma phenotype with genetic screening pending.\n* Able to give consent\u002Fparent or guardian able to give consent.\n\nExclusion Criteria:\n\n* Patients unable or unwilling to undertake consent or clinical testing.\n* Patients unwilling to donate a saliva or blood sample in order to establish the genetic cause of their condition.",true,"ALL",{"count":68,"type":69},100,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is undertake a detailed phenotypic and genotypic study of patients with ocular and secondary cancers due to mutations in the RB1 gene. Our research sequencing approach will allow advanced insight to for further detailed genotypic understanding of parent-of-origin for valuable insight into the genotype-phenotype relationship of this cancer syndrome.",[73,74,75,76,77],"Retinoblastoma Bilateral","Retinoblastoma Unilateral","Retinoblastoma, Extraocular","Retinoblastoma, Recurrent","Retinoblastoma",[79,80],"retinoblastoma","parent-of-origin","2026-03-17",{"date":83,"type":84},"2026-03-18","ACTUAL",{"date":86,"type":69},"2026-03-16",{"date":88,"type":69},"2031-01-01",{"name":5,"class":6},1]